Horm Metab Res 2020; 52(07): 471-484
DOI: 10.1055/a-1172-1352
Review

Endocrine Conditions and COVID-19

1  Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland, USA
2  Clinical Research Branch, National Institute of Environmental Health Sciences, NIH, North Carolina, USA
,
1  Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland, USA
,
Crystal D. C. Kamilaris
1  Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland, USA
,
Graeme Eisenhofer
3  Institute of Clinical Chemistry and Laboratory Medicine, and Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
,
4  Endocrinology Division, Internal Medicine Department, University Hospital “Dr. Jose E. Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
5  Plataforma INVEST-KER Unit Mayo Clinic, School of Medicine, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
,
Michelle Hajdenberg
6  College of Arts and Sciences at Washington University in St. Louis, Saint Louis, Missouri, USA
,
Joselyne Tonleu
2  Clinical Research Branch, National Institute of Environmental Health Sciences, NIH, North Carolina, USA
,
Janet E. Hall
2  Clinical Research Branch, National Institute of Environmental Health Sciences, NIH, North Carolina, USA
,
7  Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada
,
Forbes Porter
8  Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA
,
Constantine A. Stratakis
1  Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland, USA
,
1  Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, Maryland, USA
› Author Affiliations
Funding Information This work was funded by the intramural research program of the National Institutes of Health.

Abstract

COVID-19 was declared a global pandemic by the WHO and has affected millions of patients around the world. COVID-19 disproportionately affects persons with endocrine conditions, thus putting them at an increased risk for severe disease. We discuss the mechanisms that place persons with endocrine conditions at an additional risk for severe COVID-19 and review the evidence. We also suggest precautions and management of endocrine conditions in the setting of global curfews being imposed and offer practical tips for uninterrupted endocrine care.



Publication History

Received: 22 April 2020

Accepted: 30 April 2020

Publication Date:
08 June 2020 (online)

© Georg Thieme Verlag KG
Stuttgart · New York